in , ,

First Light Biosciences Awarded Anthrax Diagnostic Contract

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness & Response (ASPR) has awarded a contract to First Light Biosciences, Inc. for “Rapid, Sensitive, and Cost-effective Anthrax test and Clinical Surge-Testing Platform.”

The contract has a base value of $5,528,873 plus potential options of up to an additional $37,429,837.

The award was made in response to Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement BARDA-BAA-13-100-SOL-00013.

First Light Biosciences, based in Bedford, Mass., develops automated medical diagnostic products for rapid, sensitive, and cost-effective biodetection, with a focus on Healthcare Associated Infections (HAI). The company’s proprietary MultiPath technology utilizes digital imaging to detect and count fluorescent targets without using magnification.

Upcoming Events

CBRNE Particles News Scan

First Responder Technologies, 911 Caller Location, Nuclear Whistle-Blowers

Ebola Biosafety & Infectious Disease Response

Ebola Biosafety and Infectious Disease Response Training